PGC-1: REGULATOR OF MITOCHONDRIAL METABOLISM IN HEART

PGC-1：心脏线粒体代谢的调节剂

• 批准号: 6402743
• 负责人: JANICE M HUSS
• 金额: $ 4.02万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-08-01 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/6402743
• 关键词: bioenergetics; cardiac myocytes; fatty acid metabolism; gene mutation; heart metabolism; laboratory mouse; laboratory rat; mitochondria; molecular pathology; peroxisome proliferator activated receptor; tissue /cell culture; ventricular hypertrophy

The adult mammalian heart utilizes fatty acids as its predominant energy source. In hypertrophy, the heart switches from fatty acid oxidation (FAO) to glucose metabolism for energy generation. The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates expression of genes encoding key FAO enzymes, FFARalpha is a nuclear receptor transcription factor that functions with co-activator proteins to activate transcription. The recently identified co-activator, PPAR gamma co- activator-1 (PGC-1), is a candidate for cooperating with PPARalpha to regulate FAO enzyme genes. Both proteins are down-regulated during cardiac hypertrophy, implicating a role for PPARalpha/PGC-1 signaling in the hypertrophy gene program. PGC-1 has also been shown to regulate genes involved in mitochondrial biogenesis by a mechanism independent of its function with PPARalpha. The specific aims are to 1) characterize the role of PPARalpha and its, co-activator, PGC-1, in the control of cardiac mitochondrial energy transduction pathways, 2) co-activator, PGC-1, in the control of cardiac mitochondrial energy transduction pathways, 3) map functional domains within the PGC-1 molecular relevant to the development of dominant inhibitory mutants, and 3) determine whether PPARalpha/PGC-1 signaling plays a primary role in the cardiac myocyte hypertrophy program. Long-term goals involve development of genetically engineered animals to investigate the roles of PGC-1 in regulating cardiac metabolism in vivo.

成年哺乳动物的心脏利用脂肪酸作为其主要能量来源。在肥厚时，心脏从脂肪酸氧化(FAO)切换到葡萄糖代谢以产生能量。过氧化物酶体增殖物激活受体α(PPARpha)调节编码粮农组织关键酶的基因的表达，FFARpha是一种核受体转录因子，与共激活蛋白一起作用于激活转录。最近发现的共激活剂PPAR-γ共激活剂-1(PGC-1)是与PPARpha合作调控FAO酶基因的候选分子。这两个蛋白在心肌肥厚过程中下调，暗示PPARpha/PGC-1信号在肥厚基因程序中发挥作用。PGC-1还被证明通过一种独立于其与PPARpha的功能的机制来调节参与线粒体生物发生的基因。其具体目的是：1)鉴定PPARpha及其共激活剂PGC-1在控制心肌线粒体能量转导通路中的作用；2)共激活剂PGC-1在控制心肌线粒体能量转导通路中的作用；3)定位PGC-1分子中与显性抑制突变体的发展相关的功能结构域；以及3)确定PPARpha/PGC-1信号在心肌细胞肥大计划中是否起主要作用。长期目标包括发展基因工程动物，以研究PGC-1在体内调节心脏代谢的作用。